Studies conducted by Papadaki and colleagues [37] showed a reduced number of CD34+ cells in the bone marrow of SLE patients and a higher expression of Fas antigen in the CD34+ cell fraction compared to controls. The gene discussed is CD34; the disease is systemic lupus erythematosus.